Aso - OmicsDI

Show results for

Unknown (1452)
Genomics (383)
Transcriptomics (211)
Proteomics (41)
Other (12)
Metabolomics (5)
Methylation profiling (1)

Organisms

Homo sapiens (132)
Mus musculus (111)
Andropogon gerardi (28)
Bacteria (28)
Borrelia (28)
Botrytis cinerea (28)
Canis lupus familiaris (28)
Clostridium perfringens (28)
Cnidaria (28)
Cricetulus griseus (28)
Eukaryota (28)
Fasciola (28)
Hepatitis B virus (28)
Human betaherpesvirus 5 (28)
Japanese encephalitis virus group (28)
Miscanthus x giganteus (28)
Mycobacterium tuberculosis (28)
Orthoflavivirus (28)
Panicum virgatum (28)
Platyhelminthes (28)
Pseudomonas aeruginosa AES-1R (28)
Rickettsia (28)
Callithrix jacchus (1)
Bos taurus (1)
Solanum lycopersicum (1)
Oryza sativa (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Macaca fascicularis (1)
Mus (1)
synthetic construct (1)

Organisms

Homo sapiens (178)
Mus musculus (113)
Mus (2)
Drosophila melanogaster (2)
oral metagenome (2)
Chromobacterium violaceum (1)
bioreactor sludge metagenome (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
synthetic construct (1)
Macaca fascicularis (1)
Mammalia (1)
riverine metagenome (1)
mouse gut metagenome (1)
Bos taurus (1)
Oryza sativa (1)
Klebsiella pneumoniae (1)
mouse metagenome (1)
Sus scrofa (1)
soil metagenome (1)

Repository

ENA (368)
geo (184)
biostudies-arrayexpress (55)
pride (28)
iProX (6)
MassIVE (4)
MetabolomicsWorkbench (3)
jPOST (2)
MetaboLights (2)
ExpressionAtlas (1)

Tissue

Cell culture (10)
Brain (6)
Brain (2)
Epithelial cell (2)
Fibroblast (2)
Liver (2)
Blood (1)
Adipose tissue (1)
Aortic arch (1)
Blood (1)
Cardiac muscle cell (1)
Cerebrospinal fluid (1)
Cervical cancer cell line (1)
Early embryonic cell (1)
Embryonic kidney cell line (1)
Heart (1)
Hepatocyte (1)
HiPSC cell (1)
Macrophage (1)
Neuron (1)
Primary cell (1)
Spinal cord (1)

Disease

Hypoxic ischemic encephalopathy (2)
Colon cancer (2)
Brain injury (1)
Adult spinal muscular atrophy (1)
Alzheimer's disease (1)
Amyotrophic lateral sclerosis (1)
Cardiovascular system disease (1)
Diabetes mellitus (1)
Huntington Disease (1)
Influenza (1)
Metabolic dysfunction-associated steatotic liver disease (1)
Obesity (1)
Retinitis pigmentosa (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (31)
Bottom-up proteomics (9)
Shotgun proteomics (7)
Top-down proteomics (7)
Data-independent acquisition (4)
ESI (3)
Data-dependent acquisition (3)
Affinity purification coupled with mass spectrometry proteomics (2)
DiaPASEF (2)
NMR spectroscopy (1)
Mass spectrometry (1)
Gel-based experiment (1)
SWATH MS (1)

Instrument Platform

Illumina HiSeq 2500 (3)
Illumina NovaSeq 6000 (3)
NextSeq 500 (3)
None (2)
Illumina HiSeq 2000 (2)
Illumina HiSeq 4000 (2)
DELL PRECISION T7500 (1)
DELL PRICISION T7500 (1)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq X (1)
Illumina MiSeq (1)
Illumina HiSeq 1500 (1)
NextSeq 550 (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Q Exactive (1)
Q Exactive HF (1)
Liquid Chromatography MS - (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2026 (50)
2025 (48)
2024 (32)
2023 (22)
2022 (22)
2016 (15)
2013 (15)
2021 (12)
2017 (9)
2019 (9)
2014 (8)
2020 (7)
2012 (7)
2018 (7)
2015 (5)
2011 (4)
2010 (2)
2009 (1)
2006 (1)

CHEBI ID

CHEBI:149474 (1)
CHEBI:62624 (1)
CHEBI:139311 (1)
CHEBI:94483 (1)
CHEBI:28619 (1)
CHEBI:11805 (1)
CHEBI:17985 (1)
CHEBI:28238 (1)
CHEBI:16296 (1)
CHEBI:30742 (1)
CHEBI:18139 (1)
CHEBI:60645 (1)
CHEBI:17822 (1)
CHEBI:22660 (1)
CHEBI:27570 (1)
CHEBI:30751 (1)
CHEBI:18186 (1)
CHEBI:28757 (1)
CHEBI:26986 (1)
CHEBI:22652 (1)
CHEBI:16811 (1)
CHEBI:17790 (1)
CHEBI:17234 (1)
CHEBI:17170 (1)
CHEBI:28300 (1)
CHEBI:15347 (1)
CHEBI:16236 (1)
CHEBI:37084 (1)
CHEBI:15676 (1)
CHEBI:16870 (1)

Metabolite Name

L-3-hydroxykynurenine (1)
Trans-3-indoleacrylic acid (1)
Indole-3-carboxaldehyde (1)
Eicosatetraynoic acid (1)
3-Hydroxyisobutyrate (1)
D-(+)-tryptophan (1)
N-acetyl-DL-tryptophan (1)
Glycocholic acid (1)
2-Hydroxyisovalerate (1)
20beta-dihydrocortisol (1)
Kynurenic acid (1)
Cortisol (1)
Myo-inositol (1)
Histidine (1)
Formate (1)
Leucine (1)
Lactic acid (1)
Glycerol (1)
Dimethylamine (1)
L-5-hydroxytryptophan (1)
Acetoacetate (1)
N-phenylacetylglutamine (1)
Valine (1)
L-kynurenine (1)
Pyroglutamate (1)
2-Hydroxybutyric acid (1)
Acetic acid (1)
Acetone (1)
Methionine (1)
Choline (1)

First Public Date

2025 (81)
2026 (61)
2024 (59)
2022 (35)
2023 (29)
2021 (20)
2019 (17)
2016 (14)
2017 (13)
2014 (11)
2018 (9)
2020 (8)
2013 (6)
2015 (5)

Classification

bacteria (2)

Study type

Transcription profiling by array (24)
RNA-seq of coding RNA (18)
RNA-seq of total RNA (3)
MicroRNA profiling by high throughput sequencing (2)
Other (2)
Methylation profiling by array (2)
Human - High-throughput sequencing (1)
ChIP-chip by array (1)
CLIP-seq (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2025 (210)
2023 (186)
2022 (164)
2024 (147)
2021 (147)
2020 (105)
2019 (90)
2018 (77)
2017 (62)
2016 (60)
2014 (40)
2015 (36)
2012 (36)
2013 (35)
2026 (27)
2011 (22)
2009 (19)
2010 (16)
2008 (11)
2006 (4)
2005 (4)
2004 (3)
2002 (3)
2007 (1)
2003 (1)
2001 (1)

Lab affiliation

IBS, KAIST (4)
1 Center for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain. 2 Institute of Health Research of Navarra (IdiSNA), Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain. (1)
1)Department of Biomolecular Medicine, Ghent University, Ghent, Belgium 2)Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium 4)Department of Pharmaceutics, Ghent University, Ghent, Belgium (1)
Assistant Professor Emory University School of Medicine, Department of Human Genetics (1)
AstraZeneca (1)
Biopharmaceutical development, R&D, AstraZeneca, Cambridge, UK (1)
Cellular & Molecular Physiology, Systems Biology Institute, Yale University (1)
Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
Clinical Neuroproteomics Group, Navarrabiomed (Spain) (1)
Department of Cancer Sciences, Cleveland Clinic, 9500 Euclid Avenue, NE60, Cleveland, OH, 44195, USA. (1)
Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Foundation, USA (1)
Department of Chemistry, Lomonosov Moscow State University, Leninskye Gory 1, 119991 Moscow, Russia (1)
Department of Medical Biochemistry and Cell biology, University of Gothenburg (1)
Department of Medicine, Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Brigham Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. (1)
IBS (Institute for Basic Science, Korea), KAIST (Korea Advanced Institute of Science & Technology) (1)
Institute for Molecular Infection Biology, Julius Maximilian University Wuerzburg Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg (1)
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany (1)
King Abdullah University of Science & Technology (KAUST), Biological Environmental Sciences and Engineering Division BESE, KAUST Environmental Epigenetics Program, Thuwal, Saudi Arabia. (1)
Laboratory of RNA Biology Institute of Molecular Genetics of the Czech Academy of Sciences Prague, Czechia (1)
Laboratory of nucleic acids biochemistry, Institute of chemical biology and fundamental medicine SB RAS, Russia (1)
MIRCen, UMR9199, CEA, CNRS, Université Paris-Saclay (1)
Musculoskeletal Biology 1, Institute of Ageing and Chronic Disease, University of Liverpool, United Kingdom. (1)
Proteomics Core Facility at Sahlgrenska Academy, University of Gothenburg (1)
The Center for Excellence in Vascular Biology, Cardiovascular Division The Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (1)

Previous page
1 / 211
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 211
Next page

Sort by:

Relevance

Page size

HF liver: Control vs. Plin2-ASO treated

Transcriptional profiling of mouse liver comparing control, scrambled-oligonucleotides (Cont)-treated mice with Perilipin 2-antisense oligonucleotides (Plin2-ASO)-treated mice. C57BL/6 mice on a high-fat diet were treated with oligonucleotides in vivo. The goal was to determine the effects of Plin2 ...

ORGANISM(S): Mus musculus

2012-12-05 | E-GEOD-37011 | biostudies-arrayexpress

Brain metabonomics of rats in sham, HIE, CO and ASO groups were compared.

Not available

ORGANISM(S): Rattus norvegicus

ST002333 | MetabolomicsWorkbench

Serum metabonomics of rats in sham, HIE, CO and ASO groups were compared.

Not available

ORGANISM(S): Rattus norvegicus

ST002329 | MetabolomicsWorkbench

Brain metabonomics of rats in CO and ASO groups from 4500m were compared.

Not available

ORGANISM(S): Rattus norvegicus

ST002483 | MetabolomicsWorkbench

ASO-treated Shank3 HT mice phosphoproteome

Decreased NMDA receptor function is a central mechanism implicated in various brain disorders, and extensive efforts to modulate NMDAR activity have been devoted in various therapeutic settings. We have previously established Slc6a20a as a novel glycine transporter, and using an antisense oligonucle...

ORGANISM(S): Mus musculus (Mouse)

2026-04-24 | PXD061258 | Pride